Klépierre

Convalescence begins

07/05/21 -"We have input the latest numbers from the full Annual Report 2020 on top of the €1.00 dividend per share. This has led to some minor changes here and there."

PDF page sample
Pages
45
Language
English
Published on
07/05/21
Download
You may also be interested by these reports :
23/12/25
The key element of our target price lies in the evaluation of GAV/NAV parameters within the framework of a SOTP.
22/12/25
Our different approach to recurring profit does not significantly change the economic value of TAG Immobilien, and the target price remains close to ...
12/12/25
We have refined the estimates and revised the initial EPS slightly upwards, notably to take into account the cancellation of shares recently decided ...
12/12/25
Change in coverage

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO